Role of neuropeptides, hormones, and growth factors in regulating thymopoiesis in middle to old age by Patel, Kalpesh & Taub, Dennis D
Role of neuropeptides, hormones, and growth factors in
regulating thymopoiesis in middle to old age
Kalpesh Patel and Dennis D Taub*
Address: Laboratory of Immunology, National Institute of Aging, Intramural Research Program, National Institutes of Health, Biomedical Research
Center, 251 Bayview Boulevard, Room 8C222, Baltimore, MD 21224, USA
*Corresponding author: Dennis D Taub (taubd@grc.nia.nih.gov)
F1000 Biology Reports 2009, 1:42 (doi:10.3410/B1-42)
The electronic version of this article is the complete one and can be found at: http://F1000.com/Reports/Biology/content/1/42
Abstract
The deterioration in adaptive immunity and T-lymphocyte output and the narrowing of the T cell
receptor repertoire with age are largely attributable to thymic involution. The loss of thymic function
with age may be due to diminished numbers of early thymic progenitors and epithelial cells, and the
loss of critical tropic factors within the thymic microenvironment. Here we review some of the
recent literature demonstrating a role for neuropeptides, hormones, and growth factors that can
influence thymopoiesis associated with stress and aging.
Introduction and context
T h ep r e s e n c eo faf u n c t i o n a li m m u n es y s t e mi s
considered critical for a host’s survival against the barrage
of foreign organisms and pathogens to which we are
exposed on a daily basis. In humans and many other
species, it has been recognized that the immune system
declines with age, a term known as ‘immunosenescence’,
which has been associated with a higher incidence of
infections, cancers, and autoimmune diseases [1-4]. Of
all the described changes in the immune system with
advancing age, the atrophy or involution of the thymus is
the most dramatic and ubiquitous. The thymus under-
goes a profound age-associated reduction in size due to
loss of cellularity and thymic epithelial cells (TECs), and
a decrease in thymopoiesis. This loss of de novo T cell
generation results in a decline in the generation of
cellular responses to new antigens and is associated with
a peripheral bias toward the expansion of memory T cells
against prior viral antigens [1-4]. Emerging evidence has
strongly suggested that thymic involution, once thought
to be a process linked with the onset of puberty (due to
increases in sex steroids and a decline in growth
hormone [GH] production, both of which have an
impact on thymic function and output), is a continuous
process not affected by the changing hormonal balance
at puberty [2]. While the precise molecular mechanism
involved in the involution process remains obscure, a
number of theories have been proposed to explain this
‘thymic menopause’, including alterations in the expres-
sion of critical cytokines, neuropeptides, and/or growth
factors within the thymic environment of the aging host
[1-3]. We shall discuss some of the more recent advances
in this area below.
Major recent advances
Neuropeptides, hormones, and growth factors produced
by various organ systems have long been associated with
effects on immune cell function [5,6] (Figure 1). Growth-
and activation-promoting effects on a number of
immune cell populations as well as growth-stimulating
effects on the thymus have been reported [1,2,5]. Here,
we review the more recent advances of several hormones,
neuropeptides, and growth factors in influencing thy-
mopoiesis and age-associated thymic loss.
Growth hormone
It has been shown that both circulating and thymic levels
of GH decrease with age and that the diminished levels
of GH occur during the more dramatic stages of thymic
involution [1,2]. It has been demonstrated that impaired
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exogenous GHin hormone-deficient dwarf and aged mice
[1,2,5-7]. Napolitano and colleagues [8] recently reported
that infusion of GH in HIV-1-infected patients increased
thymic mass and output as well as the number of
circulating naïve and total CD4
+ T cells and thymic T cell
output in the circulation. Knockout mouse and various
stress models have also suggested that GH may directly
and/or indirectly promote T-progenitor cell survival
duringconditions of trauma and stress[1,5,7].GHshould
beassessedclinicallyfortheabilitytopromote(a)thymus
regeneration and production of naïve T cells in adults and
(b) multilineage hematopoietic recovery from myeloa-
blative therapy. Despite these findings, it seems likely that
Figure 1. Neuropeptide interactions with the thymus
The crosstalk between the various neuronal, endocrine and immune systems appears to be mediated via the production of interactions with soluble
immune and neuroendocrine mediators. Several hormonal and neuropeptide systems, including sex hormones (such as testosterone and growth
hormone secretagogue receptor), adrenal and thyroid hormones (corticosteroids, cortisol, adrenaline, and thyroid-stimulating hormone), pituitary
hormones (growth hormone), and metabolic hormones (leptin, ghrelin, and insulin-like growth factor-1), have been shown to influence immune
activation and thymic function. These mediators provide the link between the endocrine, central nervous, and immune systems and constitute specific
axes of interactions. Immune cells, in their resting state or upon activation, express cell surface receptors for these hormones and peptides, permitting
responses to these ligands. In states of stress, trauma, and disease and during aging, these organ systems are activated and release mediators to facilitate
crosstalk with the immune system, affecting both thymopoiesis and hematopoiesis. The immune system similarly produces factors that feedback and
communicate with these organ systems. CNS, central nervous system; GC, glucocorticoid; GH, growth hormone; GHS, growth hormone secretagogue;
GnRH, gonadotropin-releasing hormone; IGF-1, insulin-like growth factor; LepR, leptin receptor; R, receptor; TLR, Toll-like receptor; TSH, thyroid-
stimulating hormone.
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myeloid development. However, under conditions of
stress and trauma, GH stimulates proliferation, exerts
antiapoptoticeffects,andamplifiessignalsassociatedwith
lymphoid and myeloid cell expansion.
Insulin-like growth factor-1
Insulin-like growth factor-1 (IGF-1) has also been of
particular interest in the context of thymic involution, as
this hormone steadily declines with age in rodents and
humans, whereas IGF-1 treatment increases thymic
cellularity and T-cell output in mice, possibly due to its
anti-apoptotic effects [1,2,4,5,9]. Mice lacking IGF-1
receptor (IGF-1R) on thymocytes demonstrate decreased
thymic output, which can be reversed by IGF-1 infusion
[10]. IGF-1 infusion increased peripheral naïve and
recent thymic emigrant populations, demonstrating a
direct effect on T cell production, not peripheral
expansion. IGF-1 administration also increased bone
marrow LSK (Lin
− Sca-1
+ c-Kit
+) cell precursor prolifera-
tion, peripheral LSK cell populations and thymocyte
populations, and proportionately expanded TEC sub-
populations and enhanced their chemokine expression.
These results suggest that IGF-1R expression on TECs
plays an important role in facilitating the increased
thymic cellularity and T cell output in response to IGF-1
administration.
Leptin
Leptin, an anorexigenic hormone that exerts significant
effects on immune responses and induces proinflamma-
tory cytokine expression [3], is produced predominantly
by fat cells and controls food intake and energy balance.
Leptin (ob/ob) and leptin receptor (db/db) mutant mice
are born with significant thymic atrophy, and reinfusion
of leptin into ob/ob results in thymic restoration [11].
Leptin infusion also prevents thymus weight loss after
lipopolysaccharide treatment but failed to stimulate
thymopoiesis [12]. Moreover, leptin infusion increases
thymocytes and TEC numbers, reduces apoptosis, and
increases T cell output and peripheral T cell receptor
(TCR) diversity in aged mice [13].
Ghrelin
Ghrelin is an orexigenic hormone characterized initially
as a GH secretagogue (GHS), secreted predominantly by
the stomach cells. More recently, ghrelin has been found
to be secreted by immune cells as well. Ghrelin and its
receptor, GHSR, are expressed in the thymus, and ghrelin
has been shown to induce thymic GH expression, which
may play a major role in enhancing thymopoiesis
[1,2,5,6,13]. Infusion of ghrelin in old mice significantly
improved the age-associated loss of thymocyte numbers
and de novo T cell output, and also increased peripheral
TCR diversity [13]. Ghrelin increased early thymic
progenitors in the thymus. Similarly, ghrelin- and
GHSR-deficient mice demonstrate an accelerated age-
associated thymic involution, which may be associated
with reduced TEC numbers in the thymus [14].
Steroidal hormones
Ablation of sex steroids like testosterone, via castration
or chemical castration or through the administration of
steroid antagonists, has been shown to induce a
profound increase in thymic mass and cellularity and
enhanced T cell output in aged mice. These changes are
maintained for quite some time and even temporary sex
steroid ablation may have a significant impact on thymic
activity and the circulating T cell repertoire [15]. A recent
study has shown that castration induces the proliferation
of medullary TECs, which results in the increased
expression of the chemokine CCL25 that assists in
recruiting more thymocyte progenitors, thus enhancing
thymopoiesis [16]. Neutralization of CCL25 prevented
thymocyte development and abrogated the increased
thymic cellularity and T cell output observed in response
to castration [16]. Together, these data have provided
new insight into the role of steroidal hormones in thymic
development and atrophy.
Keratinocyte growth factor
Keratinocyte growth factor (KGF) increases thymocyte
numbers via induction of triple-negative cell division
and also increased double-positive cells and thymic
output. KGF induces the expression of additional growth
factors in the thymus to exert these effects [17]. KGF
infusion enhances thymic cellularity, increases naïve
CD4
+ T cell output, and increases antibody production
in aged mice [18]. KGF also increases the number of
TECs, reorganizes thymic architecture, and increases
interleukin-7 expression, which is critical for thymocyte
development, in aged mice as well as in an aging model
using Klotho knockout (kl/kl) mice. kl/kl mice develop
premature thymic atrophy and disruption of thymic
microenvironmental organization, which can be restored
by KGF infusion [19].
Other factors
There are numerous cytokines, growth factors, glucocor-
ticoids, neurotrophins, and thymic hormones that have
been shown to influence thymic development and
integrity in response to stress and age. Although it is
beyond the scope of this literature update to discuss all of
these systems and neuropeptides, several review articles
discussing the expression of these neuropeptides and
growth factors within immune tissues and their effects
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immunosuppression, and aging are available
[1,2,7,9,12,15,20-28].
Future directions
The central nervous, endocrine, and immune systems
cross-communicate with each other through multiple
anatomical and hormonal neuropeptide routes. Interac-
tions between these systems are highly controlled and
are critical for the maintenance of a homeostatic balance
within the body. Any alterations in the balance between
these systems in response to disease, stress, or injury may
lead to significant changes in thymic development and
immune responsiveness. While significant progress has
been made in many areas of study, more focused studies
are needed to assess the biological and molecular roles
that each of these neuropeptides and hormones plays in
hematopoiesis and thymopoiesis and how disruption
within one or more of these compartments may
influence a host’s ability to regulate inflammation,
disease development, or wound healing. Understanding
such relationships may reveal possible therapeutics to
restore and optimize thymic function.
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